What does CUSIP 452521107 represent in this 13F holders report?

CUSIP 452521107 is the security identifier for IMMR - IMMERSION CORP - Common Stock, $0.001 par value used to aggregate holder disclosures.

How many institutions held IMMR - IMMERSION CORP - Common Stock, $0.001 par value in Q1 2022?

86 institutional investors reported IMMR - IMMERSION CORP - Common Stock, $0.001 par value for Q1 2022. Use the holders table for investor-level position and value details.

IMMERSION CORP - Common Stock, $0.001 par value (IMMR)

CUSIP: 452521107

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Common Stock, $0.001 par value
Total 13F shares: 14,095,980
Total 13F value: $76,741,673
Share change: -983,552
Put/Call ratio: 103%
SEC-reported price per share: $5.56
Number of holders: 86
Value change: -$5,505,959
Number of buys: 38
Number of sells: 51
Shares outstanding: 33,217,473

Security key

452521107

Report period

Q1 2022

Institutions

Top holders

IMMR full security history Ownership snapshot Full 13F holder table IMMERSION CORP SEC filings IMMERSION CORP company facts IMMERSION CORP 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of IMMR - IMMERSION CORP - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Invenomic Capital Managem...

Disclosed value leader

Invenomic Capital Managem...

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 5.1% Showing 1-6 of 15 holder rows.

Quick read

Invenomic Capital Management LP leads the comparable SEC ownership view at 5.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Invenomic Capital Management LP's linked filing trail.

Comparable ownership Top 5

Invenomic Capital Management LP 5.1%

VANGUARD GROUP INC 4%

MILLENNIUM MANAGEMENT LLC 3.8%

ROYCE & ASSOCIATES LP 3.1%

Portolan Capital Management, LLC 2.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Invenomic Capital Management LP	13F Company 13F	5.1%	$9,698,000 1,698,555 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	4%	$7,589,000 1,328,965 shares	—	31 Dec 2021
MILLENNIUM MANAGEMENT LLC	13F Company 13F	3.8%	$7,220,000 1,264,364 shares	—	31 Dec 2021
ROYCE & ASSOCIATES LP	13F Company 13F	3.1%	$5,908,000 1,034,662 shares	—	31 Dec 2021
Portolan Capital Management, LLC	13F Company 13F	2.3%	$4,315,000 755,693 shares	—	31 Dec 2021
STATE STREET CORP	13F Company 13F	2%	$3,819,000 668,866 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

14,095,980

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %